IMRALDI

This brand name is authorized in Austria, Cyprus, Germany, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, United Kingdom

Active ingredients

The drug IMRALDI contains one active pharmaceutical ingredient (API):

1 Adalimumab
UNII FYS6T7F842 - ADALIMUMAB

Adalimumab binds specifically to TNF and neutralizes the biological function of TNF by blocking its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab also modulates biological responses that are induced or regulated by TNF, including changes in the levels of adhesion molecules responsible for leukocyte migration (ELAM-1, VCAM-1, and ICAM-1 with an IC50 of 0.1-0.2 nM).

Read about Adalimumab

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L04AB04 Adalimumab L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AB Tumor necrosis factor alpha (TNF-α) inhibitors
Discover more medicines within L04AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 14155930, 14155953, 14155982, 14156013, 14448299, 15270544, 15270550, 15300736, 15300742, 15300759, 15317174, 15317180, 15317197, 15317205, 15371417, 15371446, 15371452, 15371469, 15374195, 15374203, 15374232, 15374249, 15530123, 15530146, 15563068, 15563074, 15563080, 15563097, 15617189, 15617195, 15617203, 15617226, 15629301, 15629318, 15629324, 15629347, 15780618, 15780624, 15780630, 15780647, 16010207, 16010213, 16010236, 16010242, 16142771, 16142825, 16623654, 16623660, 16623677, 16623683, 17312577, 17586234, 17586240, 17586257, 17586263
Country: EE Ravimiamet Identifier(s): 1752612, 1752623, 1752634, 1752645, 1775044, 1775055, 1775066, 1775077
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1171216001, 1171216005
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 390451, 506218
Country: FR Base de données publique des médicaments Identifier(s): 61192750, 69567729
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 364421, 364603
Country: IE Health Products Regulatory Authority Identifier(s): 88953, 88954
Country: IT Agenzia del Farmaco Identifier(s): 045616012, 045616024, 045616036, 045616048, 045616051, 045616063, 045616075, 045616087, 045616099, 045616101, 045616113, 045616125, 045616137, 045616149, 045616152, 045616164, 045616176
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1083796, 1083797, 1083798, 1083799, 1085249, 1085250, 1085251, 1085252, 1088337
Country: NL Z-Index G-Standaard, PRK Identifier(s): 106348, 84492
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100400630, 100411504
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W65223001, W65224001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.